These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2805631)

  • 1. Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiency.
    Matzke GR; Millikin SP; Kovarik JM
    Clin Pharm; 1989 Nov; 8(11):800-6. PubMed ID: 2805631
    [No Abstract]   [Full Text] [Related]  

  • 2. Gentamicin, tobramycin and netilmicin pharmacokinetics in plasma and pleural fluid.
    Limthongkul S; Poshyachinda M; Charoenlap P; Nuchprayoon C
    J Med Assoc Thai; 1988 Oct; 71(10):541-7. PubMed ID: 3249161
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of netilmicin and tobramycin therapy in patients with renal impairment.
    Gorse GJ; Bernstein JM; Cronin RE; Etzell PS
    Scand J Infect Dis; 1992; 24(4):503-14. PubMed ID: 1411317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Netilmicin in comparison with tobramycin in the therapy of severe infections in nephropathic patients].
    Chiarini C; Marchesi E; Rigotti A; Spongano M; Galleri C
    Minerva Urol Nefrol; 1985; 37(1):29-33. PubMed ID: 4049190
    [No Abstract]   [Full Text] [Related]  

  • 7. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)].
    Marre R; Abraham M; Freiesleben H; Sack K
    Arzneimittelforschung; 1979; 29(6):940-5. PubMed ID: 582788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin sulfate: a comparative evaluation of antimicrobial activity, pharmacokinetics, adverse reactions and clinical efficacy.
    Craig WA; Gudmundsson S; Reich RM
    Pharmacotherapy; 1983; 3(6):305-15. PubMed ID: 6361701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients.
    Chelluri L; Warren J; Jastremski MS
    Chest; 1989 Jun; 95(6):1295-7. PubMed ID: 2721269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter comparative evaluation of netilmicin and gentamicin in adult patients. Efficacy and safety.
    Herting RL; Lorber RR; Miller M; Danzig MR
    Arzneimittelforschung; 1981; 31(2):366-70. PubMed ID: 7194655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
    Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Netilmicin in the treatment of severe or complicated urinary tract infections.
    Peddie BA; Bailey RR; Blake E; Summerfield MJ
    N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of netilmicin therapy of hospitalized patients with gram-negative infections.
    Meyers BR; Hirschman SZ; Strougo LG; Wormser GP
    Mt Sinai J Med; 1981; 48(1):42-6. PubMed ID: 7010122
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical netilmicin compared with tobramycin in the treatment of external ocular infection.
    Milazzo G; Papa V; Carstocea B; Chercota G; Rodica P; Gafencu O; Santocono M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):243-8. PubMed ID: 10363623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.